Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03077438
What this trial is testing

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,000
Testing effectiveness (Phase 2)Study completedNCT00874549
What this trial is testing

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Sanofi Pasteur, a Sanofi Company 216
Early research (Phase 1)Study completedNCT01855945
What this trial is testing

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627
Early research (Phase 1)Study completedNCT01403155
What this trial is testing

A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

Who this might be right for
Healthy
Inovio Pharmaceuticals 22
Early research (Phase 1)Study completedNCT01560793
What this trial is testing

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Who this might be right for
Influenza
VaxInnate Corporation 224
Post-approval studies (Phase 4)UnknownNCT05104216
What this trial is testing

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD

Who this might be right for
COVID-19Chronic BronchitisCOPD
China National Biotec Group Company Limited 400
Early research (Phase 1)Active Not RecruitingNCT06962904
What this trial is testing

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

Who this might be right for
Rotavirus Infections
Centers for Disease Control and Prevention 50
Early research (Phase 1)Study completedNCT00000904
What this trial is testing

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)UnknownNCT04398147
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

Who this might be right for
COVID-19
CanSino Biologics Inc. 696
Early research (Phase 1)UnknownNCT05198752
What this trial is testing

Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Stemirna Therapeutics 30
Large-scale testing (Phase 3)Looking for participantsNCT07348692
What this trial is testing

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Who this might be right for
Pneumococcal ImmunizationHealthy Volunteers
Sanofi 2,195
Early research (Phase 1)Study completedNCT03357263
What this trial is testing

Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Who this might be right for
Influenza, Human
Green Cross Corporation 40
Early research (Phase 1)Not Yet RecruitingNCT07414953
What this trial is testing

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Who this might be right for
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT00127153
What this trial is testing

V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

Who this might be right for
HealthyPneumococcal Infections
Merck Sharp & Dohme LLC 130
Post-approval studies (Phase 4)Study completedNCT00657657
What this trial is testing

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 29
Early research (Phase 1)Study completedNCT05203601
What this trial is testing

A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.

Who this might be right for
Tumor
Shanghai Institute Of Biological Products 36
Testing effectiveness (Phase 2)Study completedNCT01513551
What this trial is testing

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 692
Testing effectiveness (Phase 2)Study completedNCT01556945
What this trial is testing

Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S

Who this might be right for
Malaria, Falciparum
U.S. Army Medical Research and Development Command 72
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Early research (Phase 1)Not Yet RecruitingNCT07703475
What this trial is testing

A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine

Who this might be right for
COVID -19
National Institute of Allergy and Infectious Diseases (NIAID) 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation